Mizzou Nurse Workload and Well-Being Study

April 30, 2026 updated by: Jennifer Hulett, University of Missouri-Columbia

Exploring the Correlation Between Workload, Stress Level, and Health Status of Nurses Through Wearable Technology and Shift Data: A Feasibility Study

This observational study will evaluate the feasibility of linking nursing workload to burnout and physiological well-being among acute care nurses. Researchers will collect data from three sources: hospital workforce management software, wearable health devices (Oura Rings), and validated surveys. Fifty nurses from intensive care and medical-surgical units at a level one trauma center will participate. The study will also include interviews to better understand workplace stressors. Findings will help identify patterns that contribute to burnout and guide the development of future interventions to support nurse well-being and improve workforce retention.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Missouri
      • Columbia, Missouri, United States, 65211
        • University of Missouri

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Registered nurses (RNs) working in intensive care and medical-surgical units at MU Health Care

Description

Inclusion Criteria:

  • RN participants must be at least 18 years of age.
  • Must be a credentialed registered nurse (RN) working fulltime (≥0.75 FTE) in the MUHC University Hospital on the surgical or cardiac ICUs, surgical specialties, or the cardiovascular unit.
  • Must own a smart phone capable of supporting latest version of the Oura app with internet connectivity (Apple iOS15 and higher; Android 8.0 and higher with Google Play services) and Bluetooth 4.0.
  • Ability to wear an Oura ring daily, 7 days/ week (at least 22 hours/day), and adhere to study procedures.
  • Able to complete informed consenting procedures.

Exclusion Criteria:

  • Known allergy or sensitivity to components of Oura ring.
  • RNs working part-time or per diem
  • Travel nurses
  • Known allergies to the Oura ring
  • Ring finger sizes incompatible with Oura Ring Gen 3 sizes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Intensive Care Unit
surgical ICU and cardiac ICU RNs
Other: Multimethod data collection
Participants will contribute data through three integrated sources: workload metrics (workforce management software to assess patient acuity and shift characteristics); biometric monitoring (physiological data collected via the Oura Ring); and self-report surveys and semi-structured interviews.
Other Names:
  • Mizzou Nurse Workload and Well-Being Study
Medical-Surgical Unit
surgical and cardiovascular units
Other: Multimethod data collection
Participants will contribute data through three integrated sources: workload metrics (workforce management software to assess patient acuity and shift characteristics); biometric monitoring (physiological data collected via the Oura Ring); and self-report surveys and semi-structured interviews.
Other Names:
  • Mizzou Nurse Workload and Well-Being Study

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: Enrollment
Acceptability is evaluated based on the number of people who were approached to participate in the study compared to the number of people who agreed to participate. Reported as a percentage rate.
Enrollment
Data completion rate
Time Frame: Enrollment through 10 weeks
Reported as percentage rate of complete data obtained at baseline, 5 weeks, and 10 weeks
Enrollment through 10 weeks
Retention rate
Time Frame: Enrollment through 10 weeks
Reported as a percentage rate reflecting the number of participants participating at study completion compared to the number of participants participating at study commencement.
Enrollment through 10 weeks
Heart rate
Time Frame: Enrollment through 10 weeks
Reported as a numerical value reflecting beats per minute.
Enrollment through 10 weeks
Heart rate variability
Time Frame: Enrollment through 10 weeks
Reported as a numerical value in (milliseconds)
Enrollment through 10 weeks
Sleep duration
Time Frame: Enrollment through 10 weeks
Reported as the total sleep time (hours and minutes)
Enrollment through 10 weeks
Sleep score
Time Frame: Enrollment through 10 weeks
Reported as a numerical value (index value) ranging from 0-100
Enrollment through 10 weeks
Resilience score
Time Frame: Enrollment through 10 weeks
Reported as a numerical score (composite index value) ranging from 0-100
Enrollment through 10 weeks
Patient Acuity score
Time Frame: From enrollment through the end of 10 weeks
The Oracle Health Workload Management Clairvia system operationalizes patient acuity in terms of the intensity of care provided by nursing staff and allows for the direct care time required per patient to be quantified. This allows capture of RNs' workload across the working shift, creating an individualized utilization value that can reported as a numerical value (score).
From enrollment through the end of 10 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The Perceived Stress Scale
Time Frame: Baseline, Week 5, Week 10
The Perceived Stress Scale (PSS) (r = .93) is a 10-item survey measuring general perceived stress over the past 1 month. Scores range 0 to 40; ≥ 14 suggests at least moderate perceived stress.
Baseline, Week 5, Week 10
The Professional Quality of Life Scale
Time Frame: Baseline
The Professional Quality of Life Scale (ProQOL) is a 30-item measure of burnout, well-being, and occupational stress from the past 30 days. ProQOL subscales include compassion satisfaction (Cronbach's α = 0.88), burnout (Cronbach's α = 0.75), and secondary traumatic stress (Cronbach's α = 0.81). Scores are interpreted as ≤ 22 (low), 23-41 (moderate), and ≥42 (high) levels of the construct being measured.
Baseline
The PROMIS-29 Profile v2.0
Time Frame: Baseline, Week 5, Week 10
The PROMIS®-29 Profile v.2.0 assesses 7 domains of mental and physical health, including anxiety, depression, fatigue, physical function, social role, sleep disturbance, pain. Raw scores are converted to T-scores with higher T-scores representing more of the construct being measured.
Baseline, Week 5, Week 10
Feasibility of Intervention Measure (FIM)
Time Frame: Week 5, Week 10
The Feasibility of Intervention Measure (FIM) is a 4-item, validated implementation outcome survey tool designed to assess how practical and achievable an intervention is within a given setting. Responses range from completely disagree to completely agree.
Week 5, Week 10
Acceptability of Intervention Measure (AIM)
Time Frame: Week 5, Week 10
The AIM is a 4-item tool that evaluates the extent to which participants perceive an intervention as agreeable, satisfactory, or appealing. Responses range from completely disagree to completely agree.
Week 5, Week 10
Intervention Appropriateness Measure (IAM)
Time Frame: Week 5, Week 10
The IAM is a 4-item tool that assesses the perceived fit or suitability of an intervention for a specific setting. Responses range from completely disagree to completely agree.
Week 5, Week 10
Qualitative Insights on Burnout and Organizational Stressors
Time Frame: Baseline
Thematic analysis of semi-structured interviews exploring nurses' perceptions of stress, workload, and well-being.
Baseline
Hours worked per week
Time Frame: Baseline through week 10
Numerical value reflecting the total number of hours a nurse worked each week.
Baseline through week 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Missouri-Columbia

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Oura Ring

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Jennifer Hulett, PhD, University of Missouri-Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 26, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 31, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 29, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 20, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 4, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 30, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2101866
  • URC-025-19 (Other Grant/Funding Number: University of Missouri Research Council)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a pilot feasibility study involving sensitive biometric and survey data from a small sample of nurses. Individual participant data (IPD) will not be shared publicly due to privacy considerations and the exploratory nature of the study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings